These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16822547)

  • 1. Genome-wide exploration of the drug action of capreomycin on Mycobacterium tuberculosis using Affymetrix oligonucleotide GeneChips.
    Fu LM; Shinnick TM
    J Infect; 2007 Mar; 54(3):277-84. PubMed ID: 16822547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Action and resistance mechanisms of capreomycin: a functional genomic perspective].
    Liu XM; Xie JP
    Yao Xue Xue Bao; 2008 Aug; 43(8):788-92. PubMed ID: 18956769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis.
    Maus CE; Plikaytis BB; Shinnick TM
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3192-7. PubMed ID: 16048924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.
    Maus CE; Plikaytis BB; Shinnick TM
    Antimicrob Agents Chemother; 2005 Feb; 49(2):571-7. PubMed ID: 15673735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the action of INH on a highly INH-resistant Mycobacterium tuberculosis strain using Genechips.
    Fu LM; Shinnick TM
    Tuberculosis (Edinb); 2007 Jan; 87(1):63-70. PubMed ID: 16890025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring drug action on Mycobacterium tuberculosis using affymetrix oligonucleotide genechips.
    Fu LM
    Tuberculosis (Edinb); 2006 Mar; 86(2):134-43. PubMed ID: 16246625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The copper (II) ion as a carrier for the antibiotic capreomycin against Mycobacterium tuberculosis.
    Manning T; Mikula R; Lee H; Calvin A; Darrah J; Wylie G; Phillips D; Bythell BJ
    Bioorg Med Chem Lett; 2014 Feb; 24(3):976-82. PubMed ID: 24424129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction topology of Mycobacterium tuberculosis genes response to capreomycin and novel clues for more drug targets.
    Zheng F; Xie J
    J Cell Biochem; 2011 Oct; 112(10):2716-20. PubMed ID: 21678479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capreomycin is active against non-replicating M. tuberculosis.
    Heifets L; Simon J; Pham V
    Ann Clin Microbiol Antimicrob; 2005 Apr; 4():6. PubMed ID: 15804353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5-MmpL5 efflux system.
    Milano A; Pasca MR; Provvedi R; Lucarelli AP; Manina G; Ribeiro AL; Manganelli R; Riccardi G
    Tuberculosis (Edinb); 2009 Jan; 89(1):84-90. PubMed ID: 18851927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Critical concentrations for resistances of tubercle bacilli to tuberactinomycin-N, viomycin, capreomycin, and lividomycin in patients treated with these agents (cross-resistance-relationships among resistances to aminoglucoside-antibiotics found during chemotherapy for tuberculosis) (author's transl)].
    Tsukamura M; Mizuno S; Murata H; Oshima T
    Kekkaku; 1975 May; 50(4-5):123-30. PubMed ID: 49449
    [No Abstract]   [Full Text] [Related]  

  • 13. The gene expression data of Mycobacterium tuberculosis based on Affymetrix gene chips provide insight into regulatory and hypothetical genes.
    Fu LM; Fu-Liu CS
    BMC Microbiol; 2007 May; 7():37. PubMed ID: 17501996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM, and TUM. II. The susceptibility of antibiotic-resistant strains which were obtained in vitro to the five antibiotics (author's transl)].
    Saito T; Fukuhara Y
    Kekkaku; 1974 Apr; 49(4):91-6. PubMed ID: 4137393
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene expression profiling analysis of Mycobacterium tuberculosis genes in response to salicylate.
    Denkin S; Byrne S; Jie C; Zhang Y
    Arch Microbiol; 2005 Nov; 184(3):152-7. PubMed ID: 16175359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of bedaquiline and capreomycin on the gene expression patterns of multidrug-resistant Mycobacterium tuberculosis H37Rv strain and understanding the molecular mechanism of antibiotic resistance.
    Miryala SK; Anbarasu A; Ramaiah S
    J Cell Biochem; 2019 Sep; 120(9):14499-14509. PubMed ID: 30989745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What do microarrays really tell us about M. tuberculosis?
    Kendall SL; Rison SC; Movahedzadeh F; Frita R; Stoker NG
    Trends Microbiol; 2004 Dec; 12(12):537-44. PubMed ID: 15539113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy.
    Voskuil MI; Visconti KC; Schoolnik GK
    Tuberculosis (Edinb); 2004; 84(3-4):218-27. PubMed ID: 15207491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug resistance of tubercle bacilli -- from the clinical point of view (author's transl)].
    Fukuhara Y
    Kekkaku; 1976 Dec; 51(12):477-87. PubMed ID: 65494
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cross-resistance of tubercle bacilli (a review) (III) (author's transl)].
    Tsukamura M
    Kekkaku; 1977 Apr; 52(4):171-5. PubMed ID: 69737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.